Evidence map›Paper›PMID 34675108›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022

Comparison of Exogenous Ketone Administration Versus Dietary Carbohydrate Restriction on Myocardial Glucose Suppression: A Crossover Clinical Trial.

Senthil Selvaraj, Kenneth B Margulies, Supritha Dugyala, Erin Schubert, Ann Tierney, Zoltan Arany, Daniel A Pryma, Svati H Shah, J Eduardo Rame, Daniel P Kelly and 1 more

Registry-linked trialOpen access · bronzeAbstract readEquivalence TrialRandomized Controlled Trial
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06510894 (Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression During Evaluation of Cardiac Inflammation on FDG-PET), which is not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06510894 recruitingnot on this mapstarted 2024, after this paper: background citation

Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression During Evaluation of Cardiac Inflammation on FDG-PET

TypeobservationalSponsorUniversity of PennsylvaniaRan2024 to 2027Enrolled40ConditionsCardiac SarcoidosisArmsSotagliflozin
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. How to prepare a patient for 18F-fluorodeoxyglucose positron emission tomography imaging to assess myocardial inflammation.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2024
    Article
  9. Human cardiac metabolism.Cell metabolism · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Utility of serum ketone levels for assessment of myocardial glucose suppression forJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  15. A level of confidence: beta-hydroxybutyrate and myocardial glucose uptake suppression onJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Senthil SelvarajDivision of Cardiology, Department of Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.
Kenneth B MarguliesDivision of Cardiology, Department of Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.
Supritha DugyalaDivision of Nuclear Medicine, Department of Radiology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.
Erin SchubertDivision of Nuclear Medicine, Department of Radiology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.
Ann TierneyDepartment of Biostatistics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.
Zoltan AranyDivision of Cardiology, Department of Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.
Daniel A PrymaDivision of Nuclear Medicine, Department of Radiology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania.
Svati H ShahDivision of Cardiology, Department of Medicine, Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina; and.
J Eduardo Rame
Daniel P KellyDepartment of Cardiology, Thomas Jefferson University, Abington, Pennsylvania.
Paco E BravoDivision of Cardiology, Department of Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania; paco.bravo@pennmedicine.upenn.edu.
University of Pennsylvania · USDuke University · USThomas Jefferson University · US

Funding

Training Program in Cardiovascular Biology and MedicineT32HL007843 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI THOMAS P. CAPPOLA, Sharlene M Day · 1996 to 2026
$11.0M
Targeting Ketone Metabolism as a Novel Heart Failure TherapyR01HL151345 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KELLY, DANIEL PATRICK, RECCHIA, FABIO A · 2020 to 2023
$3.2M
NHLBI NIH HHS R01 HL151345NHLBI NIH HHS T32 HL007843
6 · The paper itself

Abstract

The ketogenic diet (KD) is the standard of care to achieve myocardial glucose suppression (MGS) for assessing inflammation using

Indexed as

KetonesKetosis3-Hydroxybutyric AcidAdultCross-Over StudiesDietary CarbohydratesFemaleFluorodeoxyglucose F18GlucoseHumansMaleYoung Adult3-Hydroxybutyric AcidDietary CarbohydratesFluorodeoxyglucose F18GlucoseKetonesFDGketogenic dietketone estermyocardial glucose uptakePET

Identifiers

PMID34675108
PMCPMC9051592
OpenAlexW3206112969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.